# Horton D R Inc: financial statements, quarterly

DHI · NYSE · CIK 882184 · [Industrials](/sectors/industrials.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/dhi.md) · [Financials](/companies/dhi/financials.md) · [Filings](/companies/dhi/filings.md) · [Insiders](/companies/dhi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dhi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [10.5 d](/filings/0000882184-25-000081.md) | [7.7](/filings/0000882184-25-000014.md) | [9.1](/filings/0000882184-25-000024.md) | [10.0](/filings/0000882184-25-000040.md) | [10.0 d](/filings/0000882184-25-000081.md) | [7.6](/filings/0000882184-26-000014.md) | [7.7](/filings/0000882184-26-000081.md) | [9.2](/filings/0000882184-26-000096.md) | [9.7 d](/filings/0000882184-25-000081.md) | [6.9](/filings/0000882184-26-000014.md) | [7.6](/filings/0000882184-26-000081.md) | [9.2](/filings/0000882184-26-000096.md) |
| Cost of revenue | $bn | [7.7 d](/filings/0000882184-25-000081.md) | [5.7](/filings/0000882184-25-000014.md) | [6.8](/filings/0000882184-25-000024.md) | [7.3](/filings/0000882184-25-000040.md) | [7.4 d](/filings/0000882184-25-000081.md) | [5.7](/filings/0000882184-26-000014.md) | [5.8](/filings/0000882184-26-000081.md) | [7.0](/filings/0000882184-26-000096.md) | [7.6 d](/filings/0000882184-25-000081.md) | [5.3](/filings/0000882184-26-000014.md) | [5.9](/filings/0000882184-26-000081.md) | [7.1](/filings/0000882184-26-000096.md) |
| Gross profit | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $bn | [0.9 d](/filings/0000882184-25-000081.md) | [0.8](/filings/0000882184-25-000014.md) | [0.9](/filings/0000882184-25-000024.md) | [0.9](/filings/0000882184-25-000040.md) | [1.0 d](/filings/0000882184-25-000081.md) | [0.9](/filings/0000882184-26-000014.md) | [0.9](/filings/0000882184-26-000081.md) | [0.9](/filings/0000882184-26-000096.md) | [1.0 d](/filings/0000882184-25-000081.md) | [0.9](/filings/0000882184-26-000014.md) | [0.9](/filings/0000882184-26-000081.md) | [1.0](/filings/0000882184-26-000096.md) |
| Interest expense | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $bn | [0.5 d](/filings/0000882184-25-000081.md) | [0.3](/filings/0000882184-25-000014.md) | [0.3](/filings/0000882184-25-000024.md) | [0.4](/filings/0000882184-25-000040.md) | [0.4 d](/filings/0000882184-25-000081.md) | [0.3](/filings/0000882184-26-000014.md) | [0.2](/filings/0000882184-26-000081.md) | [0.3](/filings/0000882184-26-000096.md) | [0.3 d](/filings/0000882184-25-000081.md) | [0.2](/filings/0000882184-26-000014.md) | [0.2](/filings/0000882184-26-000081.md) | [0.3](/filings/0000882184-26-000096.md) |
| Net income | $bn | [1.5 d](/filings/0000882184-25-000081.md) | [0.9](/filings/0000882184-25-000014.md) | [1.2](/filings/0000882184-25-000024.md) | [1.4](/filings/0000882184-25-000040.md) | [1.3 d](/filings/0000882184-25-000081.md) | [0.8](/filings/0000882184-26-000014.md) | [0.8](/filings/0000882184-26-000081.md) | [1.0](/filings/0000882184-26-000096.md) | [0.9 d](/filings/0000882184-25-000081.md) | [0.6](/filings/0000882184-26-000014.md) | [0.6](/filings/0000882184-26-000081.md) | [0.9](/filings/0000882184-26-000096.md) |
| Diluted EPS | $ per share | not reported | [2.82](/filings/0000882184-25-000014.md) | [3.52](/filings/0000882184-25-000024.md) | [4.10](/filings/0000882184-25-000040.md) | not reported | [2.61](/filings/0000882184-26-000014.md) | [2.58](/filings/0000882184-26-000081.md) | [3.36](/filings/0000882184-26-000096.md) | not reported | [2.03](/filings/0000882184-26-000014.md) | [2.24](/filings/0000882184-26-000081.md) | [3.20](/filings/0000882184-26-000096.md) |
| Basic EPS | $ per share | not reported | [2.84](/filings/0000882184-25-000014.md) | [3.54](/filings/0000882184-25-000024.md) | [4.12](/filings/0000882184-25-000040.md) | not reported | [2.63](/filings/0000882184-26-000014.md) | [2.59](/filings/0000882184-26-000081.md) | [3.37](/filings/0000882184-26-000096.md) | not reported | [2.03](/filings/0000882184-26-000014.md) | [2.25](/filings/0000882184-26-000081.md) | [3.21](/filings/0000882184-26-000096.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [3.9](/filings/0000882184-24-000057.md) | [3.3](/filings/0000882184-24-000014.md) | [3.1](/filings/0000882184-24-000027.md) | [3.0](/filings/0000882184-24-000039.md) | [4.5](/filings/0000882184-25-000081.md) | [3.1](/filings/0000882184-25-000014.md) | [2.5](/filings/0000882184-25-000024.md) | [2.6](/filings/0000882184-25-000040.md) | [3.0](/filings/0000882184-26-000096.md) | [2.5](/filings/0000882184-26-000014.md) | [1.9](/filings/0000882184-26-000081.md) | [2.1](/filings/0000882184-26-000096.md) |
| Total assets | $bn | [32.6](/filings/0000882184-24-000057.md) | [33.4](/filings/0000882184-24-000014.md) | [34.4](/filings/0000882184-24-000027.md) | [35.2](/filings/0000882184-24-000039.md) | [36.1](/filings/0000882184-25-000081.md) | [35.0](/filings/0000882184-25-000014.md) | [35.7](/filings/0000882184-25-000024.md) | [36.4](/filings/0000882184-25-000040.md) | [35.5](/filings/0000882184-26-000096.md) | [34.6](/filings/0000882184-26-000014.md) | [35.6](/filings/0000882184-26-000081.md) | [36.5](/filings/0000882184-26-000096.md) |
| Total liabilities | $bn | [9.4](/filings/0000882184-24-000057.md) | [9.8](/filings/0000882184-24-000014.md) | [10.1](/filings/0000882184-24-000027.md) | [10.0](/filings/0000882184-24-000039.md) | [10.3](/filings/0000882184-25-000081.md) | [9.6](/filings/0000882184-25-000014.md) | [10.8](/filings/0000882184-25-000024.md) | [11.8](/filings/0000882184-25-000040.md) | [10.7](/filings/0000882184-26-000096.md) | [10.1](/filings/0000882184-26-000014.md) | [11.4](/filings/0000882184-26-000081.md) | [12.1](/filings/0000882184-26-000096.md) |
| Shareholders' equity | $bn | [22.7](/filings/0000882184-24-000057.md) | [23.2](/filings/0000882184-24-000014.md) | [23.8](/filings/0000882184-24-000027.md) | [24.7](/filings/0000882184-24-000039.md) | [25.3](/filings/0000882184-25-000081.md) | [24.9](/filings/0000882184-25-000014.md) | [24.3](/filings/0000882184-25-000024.md) | [24.1](/filings/0000882184-25-000040.md) | [24.2](/filings/0000882184-26-000096.md) | [24.0](/filings/0000882184-26-000014.md) | [23.6](/filings/0000882184-26-000081.md) | [23.8](/filings/0000882184-26-000096.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2,043 d](/filings/0000882184-25-000081.md) | [(153)](/filings/0000882184-25-000014.md) | [(317) d](/filings/0000882184-25-000024.md) | [698 d](/filings/0000882184-25-000040.md) | [1,962 d](/filings/0000882184-25-000081.md) | [647](/filings/0000882184-26-000014.md) | [(436) d](/filings/0000882184-26-000081.md) | [739 d](/filings/0000882184-26-000096.md) | [2,472 d](/filings/0000882184-25-000081.md) | [854](/filings/0000882184-26-000014.md) | [(413) d](/filings/0000882184-26-000081.md) | [439 d](/filings/0000882184-26-000096.md) |
| Capital expenditure | $m | [40.3 d](/filings/0000882184-25-000081.md) | [47.6](/filings/0000882184-25-000014.md) | [23.7 d](/filings/0000882184-25-000024.md) | [62.0 d](/filings/0000882184-25-000040.md) | [32.0 d](/filings/0000882184-25-000081.md) | [13.3](/filings/0000882184-26-000014.md) | [34.3 d](/filings/0000882184-26-000081.md) | [46.0 d](/filings/0000882184-26-000096.md) | [43.8 d](/filings/0000882184-25-000081.md) | [27.4](/filings/0000882184-26-000014.md) | [37.2 d](/filings/0000882184-26-000081.md) | [42.0 d](/filings/0000882184-26-000096.md) |
| Dividends paid | $m | [84.3 d](/filings/0000882184-25-000081.md) | [99.9](/filings/0000882184-25-000014.md) | [99.2 d](/filings/0000882184-25-000024.md) | [98.4 d](/filings/0000882184-25-000040.md) | [97.7 d](/filings/0000882184-25-000081.md) | [129](/filings/0000882184-26-000014.md) | [126 d](/filings/0000882184-26-000081.md) | [122 d](/filings/0000882184-26-000096.md) | [118 d](/filings/0000882184-25-000081.md) | [132](/filings/0000882184-26-000014.md) | [130 d](/filings/0000882184-26-000081.md) | [127 d](/filings/0000882184-26-000096.md) |
| Share repurchases | $m | [436 d](/filings/0000882184-23-000115.md) | [398](/filings/0000882184-24-000014.md) | [402 d](/filings/0000882184-24-000027.md) | [400 d](/filings/0000882184-24-000039.md) | [600 d](/filings/0000882184-24-000057.md) | [1,100](/filings/0000882184-25-000014.md) | [1,500 d](/filings/0000882184-25-000081.md) | [1,000 d](/filings/0000882184-25-000040.md) | [700 d](/filings/0000882184-25-000081.md) | [670](/filings/0000882184-26-000014.md) | [930 d](/filings/0000882184-26-000081.md) | [600 d](/filings/0000882184-26-000096.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [347](/filings/0000882184-24-000014.md) | [345](/filings/0000882184-24-000027.md) | [342](/filings/0000882184-24-000039.md) | [336](/filings/0000882184-25-000014.md) | [333](/filings/0000882184-25-000024.md) | [330](/filings/0000882184-25-000040.md) | [323](/filings/0000882184-26-000014.md) | [314](/filings/0000882184-26-000081.md) | [305](/filings/0000882184-26-000096.md) | [293](/filings/0000882184-26-000014.md) | [289](/filings/0000882184-26-000081.md) | [283](/filings/0000882184-26-000096.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 279,701,267 at 2026-07-16, from the cover of the [10-Q filed 2026-07-23](/filings/0000882184-26-000096.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.